 |
|
The Treatment of Severe PsoriasisA National Survey
Patwin E. Peckham, MD;
Gerald D. Weinstein, MD;
Jerry L. McCullough, PhD
Arch Dermatol. 1987;123(10):1303-1307.
Abstract
• In 1974, we conducted a randomized survey of dermatologists to determine trends in the use of chemotherapeutic agents for psoriasis. The present survey updates and extends the earlier one to include phototherapy, photochemotherapy, and other modalities being used in the treatment of psoriasis too extensive or severe for topical agents alone. Questionnaires were sent to approximately 20% of dermatologists nationwide and also to all training/research programs. Results of the survey include: (1) approximately 523 000 patients with psoriasis were treated by dermatologists in 1984, and 30% of these were severe enough to require more than topical care; (2) the majority of dermatologists use ultraviolet B (71%) and methotrexate (58%), while 36% use psoralen and ultraviolet A; (3) creatinine clearance rates and liver biopsy specimens are being obtained for approximately half of methotrexate-treated patients; and (4) of those physicians using methotrexate, most (74%) use weekly divided orally administered methotrexate doses.
(Arch Dermatol 1987;123:1303-1307)
Author Affiliations
From the Department of Dermatology, College of Medicine, University of California, Irvine.
Footnotes
Accepted for publication April 8, 1987.
Presented in part at the American Academy of Dermatology Meeting, San Diego, June 23, 1985.
Reprint requests to Department of Dermatology, University of California at Irvine, Irvine, CA 92717 (Dr Weinstein).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Methotrexate-Induced Cirrhosis Requiring Liver Transplantation in Three Patients With Psoriasis: A Word of Caution in Light of the Expanding Use of This 'Steroid-Sparing' Agent
Gilbert et al.
Arch Intern Med 1990;150:889-891.
ABSTRACT
Will 1,25-Dihydroxyvitamin D3, MC 903, and Their Analogues Herald a New Pharmacologic Era for the Treatment of Psoriasis?
Holick
Arch Dermatol 1989;125:1692-1697.
ABSTRACT
Detection of Hepatotoxicity Associated With Methotrexate Therapy for Psoriasis
O'Connor et al.
Arch Dermatol 1989;125:1209-1217.
ABSTRACT
Psoriasis Practices
Baughman
Arch Dermatol 1987;123:1299-1300.
ABSTRACT
|
